Moving Biotech completes enrollment in Phase 2a INFLAM MOTION study evaluating first-in-class intra-articular GLP-1 therapy targeting synovitis as a driver of pain and disease progression in knee ...
Teeth and bones are among the hardest structures in the human body, but certain inherited conditions can rob them of that ...
The findings reflect a broader effort through the CU Anschutz Combat Medicine Research Center to improve oxygen therapy across the continuum of care. Prior research, led by Drs. Douin and Ginde, has ...
The mechanistic advantages of Opamtistomig have been validated in multiple tumor types, including extrapulmonary neuroendocrine carcinoma (EP-NEC), non-small cell lung cancer (NSCLC), small cell lung ...
Invenio Imaging's first AI product, NIO ® Glioma Reveal, is CE-marked and available for clinical use in Europe. NIO ® Lung ...
To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru Inc. call. An archived version of the audio webcast will be ...
A pair of wearable stickers may transform diagnostic sweat testing for cystic fibrosis (CF), a genetic disorder that causes ...
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...
Probiotic-associated invasive infections were rare in very preterm infants, according to a large retrospective cohort study. Among over 100,000 very preterm infants, 11 developed Bifidobacterium or ...
A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results